Shares in Cardinal Health (NYSE:CAH) are rising in early morning trading after the medical device maker posted second quarter fiscal year 2019 earnings that handily topped Wall Street analyst’s expectations. The Dublin, Ohio-based company posted profits of $280 million, or 93¢ per share, on sales of $37.7 billion for the three months ended December 31, seeing […]
Cardinal Health
ReShape Lifesciences CEO Gladney to resign | Personnel Moves – January 29, 2019
ReShape Lifesciences (NSDQ:RSLS) said yesterday that its prez & CEO Dan Gladney will resign from his positions with the company, effective March 31. Gladney will remain with the company as board chair, San Clemente, Calif.-based ReShape Lifesciences said. The company’s board of directors said they will immediately begin to look for a replacement, according to an […]
Cardinal Health launches supply chain solution
Cardinal Health has launched a supply chain automation solution that is designed to address the challenges in the operating room. The single health system-wide platform allows hospitals to streamline OR processes, reduce costs and improve efficiency with real-time inventory visibility and prescriptive analytics. The system also offers real-time insights and wrap-around logistics. Get the full […]
Cardinal Health’s fiscal Q1 tops estimates
Cardinal Health (NYSE:CAH) today posted fiscal first-quarter results that handily topped the average estimates on surging profits and confirmed its earnings outlook for the rest of fiscal 2019. The Dublin,Ohio-based healthcare giant reported profits of $593 million, or $1.94 per share, on sales of $35.21 billion for the three months ended Sept. 30, for a whopping […]
Cardinal Health’s Cordis launches Mynx Control vascular closure system
Cardinal Health (NYSE:CAH) subsidiary Cordis said last Friday that it launched the Mynx Control vascular closure device intended for sealing 5-7 French femoral arterial access sites. The newly launched system is intended to reduce time to hemostasis and ambulation after diagnostic or interventional procedures, the Dublin, Ohio-based company said. The system also includes a next-generation deployment system designed to […]
NuVasive taps Medtronic surgical innovation prez Barry as new CEO | Personnel Moves – October 19, 2018
NuVasive (NSDQ:NUVA) said today it named Medtronic (NYSE:MDT) surgical innovations prez J. Barry as its new CEO, replacing Gregory Lucier, effective November 5. Barry will also join the company’s board of directors, where Lucier will continue to serve as board chair and aid in transition efforts, the San Diego-based company said. NuVasive also said that it promoted current strategy, […]
The 10 largest medical device companies in the world
Medtronic and Johnson & Johnson remain the world’s largest medical device companies. But after that, the roster is radically shifting amid a slew of mergers and acquisitions. In some cases such as GE, Philips and Siemens, major multinationals are breaking apart. We’ve sifted through data from public companies’ annual reports and other publicly disclosed information, […]
Cardinal Health shares rise on Q4, FY2018 earnings beat
Shares in Cardinal Health (NYSE:CAH) rose today after the medtech giant beat expectations on Wall Street with its fourth quarter and full fiscal year 2018 earnings results. The Dublin, Ohio-based company posted losses of $1.2 billion, or $3.76 per share, on sales of $35.3 billion for the three months ended June 30, seeing profits swing to […]
Cardinal Health deals majority stake in NaviHealth to PE shop CD&R
Cardinal Health (NYSE:CAH) said this week it divested itself of its majority stake in NaviHealth to private equity firm Clayton, Dubilier & Rice, with Cardinal Health retaining the call right to reacquire the business. NaviHealth provides post-acute car programs to hospital systems, health planst, physician groups and healthcare providers as part of value-based care programs, Cardinal […]
FDA panel backs Cardinal Health’s Incraft stent graft
Cardinal Health (NYSE:CAH) said this week that the FDA Circulatory System Devices Panel of its Medical Devices Advisory Committee issued a favorable recommendation on the premarket approval application for the company’s Incraft abdominal aortic aneurysm stent graft system. The panel voted 11 to 4 in favor of the Incraft system, which is designed as an advanced […]
Cardinal Health’s Cordis wins date with FDA panel for Incraft AAA stent graft
Cardinal Health (NYSE:CAH) subsidiary Cordis this week won a June date with an FDA panel looking to discuss the premarket approval application for its InCraft AAA stent graft system designed for treating infrarenal abdominal aortic aneurysms. On June 12, the FDA’s Medical Device Advisory Committee’s Circulatory Systems Devices Panel will meet to discuss possible marketing applications for […]